| Ovarian Cancer |
1 |
1 |
| Cancer |
0 |
0.87 |
| Cancer Pain |
0 |
0.54 |
| Acute Pain |
0 |
0.44 |
| Food and Drug Administration (FDA) |
0 |
0.99 |
| Surgery |
0 |
0.98 |
| Gastroesophageal Reflux Disease |
0 |
0.17 |
| Tumor |
0 |
0.16 |
| Tissue |
0 |
0.11 |
| Abdominal Pain |
0 |
0.09 |
| Pain Management |
0 |
0.07 |
| Patient Safety |
0 |
0.07 |
| Pregnancy |
0 |
0.07 |
| Abdomen |
0 |
0.05 |
| Adverse Effects |
0 |
0.05 |
| Dyspepsia |
0 |
0.05 |
| Grant |
0 |
0.05 |
| Health Care Quality, Access, and Evaluation |
0 |
0.05 |
| Indiana |
0 |
0.05 |
| Intravenous |
0 |
0.05 |
| Nausea |
0 |
0.05 |
| Orphan Drugs |
0 |
0.05 |
| Other Specialty |
0 |
0.05 |
| Pain |
0 |
0.05 |
| Preoperative |
0 |
0.05 |
| Receptors |
0 |
0.05 |
| Thorax |
0 |
0.05 |
| Social Determinants of Health |
0 |
0.04 |